共 55 条
- [1] Wallace KB, Sardao VA, Oliveira PJ., Mitochondrial determinants of doxorubicin-induced cardiomyopathy, Circ Res, 126, 7, pp. 926-941, (2020)
- [2] Sciarretta S, Maejima Y, Zablocki D, Sadoshima J., The role of autophagy in the heart, Annu Rev Physiol, 80, pp. 1-26, (2018)
- [3] Wu L, Wang L, Du Y, Zhang Y, Ren J., Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity, Trends Pharmacol Sci, 44, 1, pp. 34-49, (2023)
- [4] Christidi E, Brunham LR., Regulated cell death pathways in doxorubicin-induced cardiotoxicity, Cell Death Dis, 12, 4, (2021)
- [5] Shi S, Chen Y, Luo Z, Nie G, Dai Y., Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy, Cell Commun Signal, 21, 1, (2023)
- [6] Tomczyk MM, Cheung KG, Xiang B, Et al., Mitochondrial Sirtuin-3 (SIRT3) prevents doxorubicin-induced dilated cardiomyopathy by modulating protein acetylation and oxidative stress, Circ Heart Fail, 15, 5, (2022)
- [7] Picca A, Mankowski RT, Burman JL, Et al., Mitochondrial quality control mechanisms as molecular targets in cardiac ageing, Nat Rev Cardiol, 15, 9, pp. 543-554, (2018)
- [8] Da Dalt L, Cabodevilla AG, Goldberg IJ, Norata GD., Cardiac lipid metabolism, mitochondrial function, and heart failure, Cardiovasc Res, 119, 10, pp. 1905-1914, (2023)
- [9] Zhao L, Qi Y, Xu L, Et al., MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2, Redox Biol, 15, pp. 284-296, (2018)
- [10] Zhang Y, Chen W, Wang Y., STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stress, Biomed Pharmacother, 125, (2020)